X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9307) 9307
Book Review (927) 927
Publication (296) 296
Newsletter (117) 117
Magazine Article (24) 24
Book Chapter (9) 9
Conference Proceeding (6) 6
Transcript (6) 6
Newspaper Article (5) 5
Trade Publication Article (2) 2
Dissertation (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (7949) 7949
humans (7907) 7907
female (5124) 5124
male (5119) 5119
prednisolone - therapeutic use (3626) 3626
adult (3410) 3410
middle aged (3391) 3391
prednisolone - adverse effects (2916) 2916
prednisolone (2720) 2720
prednisolone - administration & dosage (2614) 2614
aged (2145) 2145
treatment outcome (1700) 1700
corticosteroids (1636) 1636
adolescent (1423) 1423
drug therapy, combination (1301) 1301
child (1100) 1100
glucocorticoids - therapeutic use (1008) 1008
abridged index medicus (982) 982
therapy (942) 942
glucocorticoids - adverse effects (842) 842
anti-inflammatory agents - therapeutic use (824) 824
animals (816) 816
immunosuppressive agents - therapeutic use (796) 796
time factors (767) 767
glucocorticoids - administration & dosage (744) 744
steroids (735) 735
retrospective studies (699) 699
medicine, general & internal (665) 665
immunosuppressive agents - adverse effects (662) 662
child, preschool (656) 656
follow-up studies (643) 643
care and treatment (623) 623
surgery (609) 609
antineoplastic combined chemotherapy protocols - therapeutic use (607) 607
risk factors (598) 598
medicine & public health (592) 592
rheumatology (585) 585
administration, oral (576) 576
transplantation (572) 572
drug therapy (567) 567
oncology (553) 553
children (547) 547
dose-response relationship, drug (545) 545
drug administration schedule (538) 538
anti-inflammatory agents - administration & dosage (532) 532
immunology (528) 528
prospective studies (528) 528
anti-inflammatory agents - adverse effects (525) 525
aged, 80 and over (523) 523
glucocorticoids (522) 522
antineoplastic combined chemotherapy protocols - adverse effects (509) 509
pediatrics (481) 481
recurrence (479) 479
pharmacology & pharmacy (464) 464
hematology (461) 461
cyclophosphamide - administration & dosage (445) 445
vincristine - administration & dosage (433) 433
analysis (416) 416
arthritis, rheumatoid - drug therapy (416) 416
ophthalmology (415) 415
remission induction (409) 409
young adult (401) 401
double-blind method (399) 399
disease (398) 398
infant (393) 393
azathioprine - therapeutic use (391) 391
chemotherapy (391) 391
dosage and administration (386) 386
research (384) 384
dermatology (383) 383
patients (377) 377
health aspects (374) 374
immunosuppressive agents - administration & dosage (372) 372
gastroenterology & hepatology (370) 370
prognosis (369) 369
management (362) 362
double-blind (351) 351
prednisolone - analogs & derivatives (349) 349
urology & nephrology (344) 344
acute disease (338) 338
cancer (338) 338
cyclophosphamide - adverse effects (331) 331
diagnosis (330) 330
kidney transplantation (327) 327
cyclosporine - therapeutic use (326) 326
biopsy (323) 323
prednisolone - pharmacology (321) 321
dexamethasone (315) 315
doxorubicin - administration & dosage (311) 311
severity of illness index (310) 310
cyclophosphamide (309) 309
asthma - drug therapy (302) 302
complications and side effects (302) 302
rheumatoid arthritis (296) 296
cyclosporine (287) 287
adrenal cortex hormones - therapeutic use (279) 279
efficacy (278) 278
methylprednisolone (276) 276
cyclophosphamide - therapeutic use (273) 273
trial (270) 270
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8051) 8051
Japanese (474) 474
German (380) 380
Russian (247) 247
French (117) 117
Spanish (36) 36
Italian (29) 29
Danish (23) 23
Hungarian (22) 22
Chinese (21) 21
Dutch (10) 10
Swedish (10) 10
Polish (7) 7
Ukrainian (7) 7
Portuguese (6) 6
Bulgarian (5) 5
Norwegian (5) 5
Turkish (4) 4
Korean (3) 3
Czech (2) 2
Hebrew (2) 2
Lithuanian (2) 2
Finnish (1) 1
Persian (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Seminars in Arthritis and Rheumatism, ISSN 0049-0172, 2016, Volume 46, Issue 6, pp. 819 - 827
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2017, Volume 377, Issue 4, pp. 338 - 351
Journal Article
Lupus, ISSN 0961-2033, 5/2018, Volume 27, Issue 6, pp. 890 - 898
Background Deflazacort (DFZ), an oxazoline derivative of prednisolone (PDN), has a dose equivalence of 1.2:1 (mg) to PDN. No study to date has compared adverse... 
prednisolone | systemic lupus erythematosus | steroids | Adverse effects | deflazacort | efficacy | DERIVATION | CRITERIA | MASS | CLASSIFICATION | INDEX | RHEUMATOLOGY | Lupus | Side effects | Nervous system diseases | Adrenocorticotropic hormone | Systemic lupus erythematosus | Intravenous administration | Antibiotics | Pituitary | Body weight | Hirsutism | Anti-DNA antibodies | Prednisolone
Journal Article
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, ISSN 0269-2813, 07/2007, Volume 26, Issue 1, pp. 8 - 20
Background Sodium-phosphate enemas are widely used to treat constipation, and are rarely associated with side effects. Aim A systematic review of the... 
PREDNISOLONE 21-PHOSPHATE ENEMAS | ELECTROLYTE ABNORMALITIES | BOWEL PREPARATION | HIRSCHSPRUNGS DISEASE | RANDOMIZED-TRIAL | PHARMACOLOGY & PHARMACY | SEVERE HYPERPHOSPHATEMIA | GASTROENTEROLOGY & HEPATOLOGY | HYPOCALCEMIC TETANY | FLEET ENEMA | BECLOMETHASONE DIPROPIONATE | FLEXIBLE SIGMOIDOSCOPY
Journal Article
Scientific Reports (Nature Publisher Group), 08/2019, Volume 9, pp. 1 - 9
Nausea and diarrhea are the most common adverse effects of nintedanib in patients with idiopathic pulmonary fibrosis (IPF). However, the clinical risk factors... 
Toxicity | Lung diseases | Diarrhea | Nausea | Patients | Risk factors | Body mass index | Side effects | Pulmonary fibrosis | Dyspnea | Fibrosis | Respiration | Health risk assessment | Prednisolone
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2015, Volume 169, Issue 5, pp. 672 - 682
This multicentre, randomized, phase II study was conducted to examine whether the addition of mogamulizumab, a humanized anti‐ CC chemokine receptor 4... 
mogamulizumab | study | CCR | randomized phase | adult T‐cell leukaemia‐lymphoma | antibody therapy | Adult T-cell leukaemia-lymphoma | Mogamulizumab | Antibody therapy | CCR4 | Randomized phase II study | randomized phase II study | adult T-cell leukaemia-lymphoma | MONOCLONAL-ANTIBODY KW-0761 | RECEPTOR | LEUKEMIA/LYMPHOMA | HEMATOLOGY | EXPRESSION | ASSOCIATION | TRANSPLANTATION | Doxorubicin - therapeutic use | Nitrosourea Compounds - adverse effects | Prednisolone - adverse effects | Nitrosourea Compounds - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Carboplatin - adverse effects | Antibodies, Monoclonal, Humanized - administration & dosage | Leukemia-Lymphoma, Adult T-Cell - drug therapy | Carboplatin - therapeutic use | Vindesine - adverse effects | Vindesine - therapeutic use | Aged, 80 and over | Adult | Female | Prednisolone - therapeutic use | Etoposide - adverse effects | Leukemia-Lymphoma, Adult T-Cell - mortality | Etoposide - therapeutic use | Treatment Outcome | Leukemia-Lymphoma, Adult T-Cell - pathology | Disease Progression | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Doxorubicin - adverse effects | Chemotherapy | Lymphomas | T cells | Leukemia | Cancer | Index Medicus | Haematological Malignancy | Research Paper
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2018, Volume 13, Issue 6, pp. e0198184 - e0198184
Background Many patients with immune thrombocytopenia (ITP) may require special attention and long-term treatment. Little is known on the efficacy and... 
AUTOIMMUNE THROMBOCYTOPENIA | TREATMENT OPTIONS | ADULT PATIENTS | INTRAVENOUS GAMMA-GLOBULIN | MANAGEMENT | ANTI-D | MEDICAL THERAPY | SAFETY | PURPURA | ROMIPLOSTIM | MULTIDISCIPLINARY SCIENCES | Prednisolone - adverse effects | Azathioprine - therapeutic use | Pyrazoles - therapeutic use | Benzoates - therapeutic use | Recombinant Fusion Proteins - adverse effects | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Immunoglobulins, Intravenous - adverse effects | Child, Preschool | Dexamethasone - adverse effects | Male | Dapsone - therapeutic use | Purpura, Thrombocytopenic, Idiopathic - drug therapy | Receptors, Fc - therapeutic use | Splenectomy | Young Adult | Aged, 80 and over | Child | Rituximab - adverse effects | Purpura, Thrombocytopenic, Idiopathic - surgery | Combined Modality Therapy | Remission Induction | Cyclosporine - therapeutic use | Dexamethasone - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Rho(D) Immune Globulin - adverse effects | Cyclosporine - adverse effects | Adolescent | Rho(D) Immune Globulin - therapeutic use | Dapsone - adverse effects | Benzoates - adverse effects | Recombinant Fusion Proteins - therapeutic use | Thrombopoietin - therapeutic use | Purpura, Thrombocytopenic, Idiopathic - therapy | Rituximab - therapeutic use | Adult | Female | Prednisolone - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Drug Resistance | Pyrazoles - adverse effects | Hydrazines - therapeutic use | Treatment Outcome | Thrombopoietin - adverse effects | Immunosuppressive Agents - adverse effects | Aged | Azathioprine - adverse effects | Hydrazines - adverse effects | Thrombocytopenic purpura | Clinical trials | Treatment outcome | Care and treatment | Analysis | Drugs | Thrombocytopenia | Therapy | Immunoglobulins | Dexamethasone | Intravenous administration | Medical treatment | Medical services | Patients | Immunosuppressive agents | Bleeding | Medicine | Remission | Clinical medicine | Azathioprine | Drug dosages | Prednisolone | Index Medicus
Journal Article